Cargando…
Epidemiological transcriptomic data supports BCG protection in viral diseases including COVID-19
Epidemiological and clinical evidence suggests that Bacille Calmette-Guérin (BCG) vaccine induced trained immunity protects against non-specific infections. Multiple clinical trials are currently underway to assess effectiveness of the vaccine in the coronavirus disease 2019 (COVID-19). However, the...
Autor principal: | Sharma, Abhay |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7959679/ https://www.ncbi.nlm.nih.gov/pubmed/33737124 http://dx.doi.org/10.1016/j.gene.2021.145574 |
Ejemplares similares
-
Inferring molecular mechanisms of dexamethasone therapy in severe COVID-19 from existing transcriptomic data
por: Sharma, Abhay
Publicado: (2021) -
Higher BCG‐induced trained immunity prevalence predicts protection from COVID‐19: Implications for ongoing BCG trials
por: Singh, Samer, et al.
Publicado: (2022) -
Is the tuberculosis vaccine BCG an alternative weapon for developing countries to defeat COVID-19?
por: Gong, Wenping, et al.
Publicado: (2021) -
BCG epidemiology supports its protection against COVID-19? A word of caution
por: Szigeti, Reka, et al.
Publicado: (2020) -
Induction of Cross-Reacting Antibodies Against the COVID-19 by BCG Vaccination in the Mouse Model
por: Rahali, Nadia, et al.
Publicado: (2022)